BRICANYL TURBOHALER 500 Mcg/Dose Powder for Inhalation
Land: Irland
Sprog: engelsk
Kilde: HPRA (Health Products Regulatory Authority)
Produktets egenskaber
(SPC)
25-04-2024
Nogle dokumenter til dette produkt er ikke tilgængelige i øjeblikket, du kan sende en anmodning til vores kundeservice, og vi vil underrette dig, så snart vi er i stand til at få dem.
Send anmodning.
Send anmodning.
Aktiv bestanddel:
TERBUTALINE SULFATE
Tilgængelig fra:
McDowell Pharmaceuticals
INN (International Name):
TERBUTALINE SULFATE
Dosering:
500 Mcg/Dose
Lægemiddelform:
Powder for Inhalation
Recept type:
Product subject to prescription which may be renewed (B)
Autorisation status:
Withdrawn
Autorisation dato:
2014-03-25
Produktets egenskaber
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Bricanyl Turbohaler 500 micrograms per metered dose, inhalation powder
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each metered dose contains 500 micrograms of Terbutaline Sulphate.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Inhalation powder
_Product imported from the UK:_
White to off white spherical particles which break into a fine powder on inhalation, contained in a plastic multi-dose
breath-actuated metered dose powder inhaler.
4 CLINICAL PARTICULARS
Terbutaline is a selective 2-adrenergic agonist recommended for the relief and prevention of bronchospasm in
bronchial asthma and in chronic bronchitis and other bronchopulmonary disorders in which bronchospasm is a
complicating factor.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Adults and Children: One inhalation (500 micrograms) (metered dose) as required. Not more than 4 inhalations should
be necessary in any 24 hour period.
Elderly: Dosage as for adults.
Instructions for use and cleaning are provided in the Patient Information Leaflet, which can be found in each pack.
4.3 CONTRAINDICATIONS
Bricanyl preparations are contra-indicated in patients with a history of sensitivity to terbutaline sulphate.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Patients should be instructed in proper use and their inhalation technique checked regularly.
Care should be taken in patients suffering from myocardial insufficiency or thyrotoxicosis.
Due to the hyperglycaemic effects of 2-stimulants, additional blood glucose measurements are initially recommended
when Bricanyl therapy is commenced in diabetic patients.
Cardiovascular effects may be seen with sympathomimetic drugs, including Bricanyl. There is some evidence from
post-marketing data and published literatur
Læs hele dokumentet
